SIN_1026379 |
8 |
+
ATGGCTTATGCTGCCCTCGTTTCACTCTTACAAACAATTGAAGAGTTCCC
TCGACCTGTGCAACAGATCCCTGTTGATCTCCATGGGAAAGTTAGCTACT
TGCTTGGAGTTCTTGAAGATTCTTTACAAACGAGCAGCCCATCAATCAGG
GTTTTGGAAGGACAAATCAGAGACGCGTCATTTGAAGCACAAGATATCAT
AAACTCCTATATATCAAGTCAAGCCATGTCAAGATCCGCAGGTTGTGGAG
TTGGTAGCTGTTTTTGGGAGATAATTTCCGCTCTCCTAGATATCTTCCCT
GCCATCCATCTATGTGAAACATGCATGGACTTGGAAGTTGAAGGCTTACA
GAAGAGTAGCAATGAAGAATTAGCTTTGCGTCTACACAAAAATTTGAAAG
GTAGGAGATACCTGATTGTGATGGATGATGTCTGGGACACCAAAGTTTGG
GATGATGCCAAAAGGTTCTTTCCAGATGATAATAACGGTAATCGGATCAT
ACTGACTACTCGTCAATCAGATGTGGCTATGTATGCGAACGCTGAAAGCC
CCATTCAGCATATGAGTCTTCTTAGTCCAGAGGCAAGTTGGGATCTATTG
CGTAAGACGGTATTTGGGCAAAAAGACTGCCCTTCTGCACTGGAGAAAAT
TGGACGGATGATTGCACGAAATTGTAAAGGACTTCCACTTGCAATTGTTG
CGATTGGCGGCCTCCTTTTCAAAGCTCATGACAACAAGCAAGAAGACTGG
GAACACATTGCCTCAGATGTTGCTGAGGGATTTGTAAGACTACCAACACC
TAAAAGCTTCAAAGAGGTGGCAGACGATTATTTCAACGATCTCAACTATA
GAAGTCTCATTCAAGTTCAAAGGAGAAATCGCAATGGTAGAGTTAAAACA
TGCATCAACTATGACATGTTGAGGGAGTTGTGCATAAAAGAAGCTTGGGA
TGATAAATTTATTCAGGTGATCAATTGGTGTATTCGCCTTTCTCCACGAG
GAAACAATCAAGGGAGGATGAGTATTCATTCAAATGGTTTGCTTTACCCT
GAAGAATTTGATGCATCATATGTCCGTTCTCTACTGTATTTTTACAGCGA
TCCCTTGGAGAGTCGATTACTATCTTTTCCTATGAGGTGCAGATTGCTCA
GGGTATTGAAAGCATTGACAATAAAGTTCCAAGAGTTTCCAAGTGGAATC
GTCGAGCTAATTCATCCCAGGTACCTTGGCTTCTCCTATAGAGGCAGGGA
CAAGTTTCCTGCATCGATACACCAACTTTTGAATCTTCAAACTTCAATTG
TTTGGCGGGTCCAATTTACATCTACCAATAAGCATATGGAAAATGCCAAA
GTTGAGGCATCTCTTGTTCGAGAGAGGTTTCTTGGCTTACCCTTTATCCT
ACACAAGTCTTGGGGAAAGATCCAGTTGTTCTAG
|
standard]
MAYAALVSLLQTIEEFPRPVQQIPVDLHGKVSYLLGVLEDSLQTSSPSIR
VLEGQIRDASFEAQDIINSYISSQAMSRSAGCGVGSCFWEIISALLDIFP
AIHLCETCMDLEVEGLQKSSNEELALRLHKNLKGRRYLIVMDDVWDTKVW
DDAKRFFPDDNNGNRIILTTRQSDVAMYANAESPIQHMSLLSPEASWDLL
RKTVFGQKDCPSALEKIGRMIARNCKGLPLAIVAIGGLLFKAHDNKQEDW
EHIASDVAEGFVRLPTPKSFKEVADDYFNDLNYRSLIQVQRRNRNGRVKT
CINYDMLRELCIKEAWDDKFIQVINWCIRLSPRGNNQGRMSIHSNGLLYP
EEFDASYVRSLLYFYSDPLESRLLSFPMRCRLLRVLKALTIKFQEFPSGI
VELIHPRYLGFSYRGRDKFPASIHQLLNLQTSIVWRVQFTSTNKHMENAK
VEASLVRERFLGLPFILHKSWGKIQLF
|
IPR000767; Disease resistance protein IPR002182; NB-ARC |